 |
Rimonabant banned in Europe The European Medicines Agency (EMEA) has banned the new antiobesity drug rimonabant in European Union. EMEA has suspended the marketing authorisation as the benefits no longer outweigh the risks of psychiatric adverse effects.
Member: Manoj Karwa |
About Us |
Contact Us |
Virtual Events |
Advertise |
Watch Introduction Video |
Press |
Partners |
Website Feedback |
LabRoots Blog |
FAQ
|
|
Home
Videos
Podcasts
Groups
Reviews
Blogs
Q&A Forum
News
Publications
Events
Jobs